Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects.
Academic Article
Publication Date:
2007
Iris type:
1.1 Articolo in rivista
Keywords:
Etanercept; Infliximab; Rheumatoid Arthritis
List of contributors:
Iannone, F; Trotta, F; Montecucco, Carlomaurizio; Giacomelli, R; Galeazzi, M; Matucci Cerinic, M; Ferri, C; Cutolo, M; Maria Bambara, L; Triolo, G; Ferraccioli, G; Valentini, G; Lapadula, G; Gisea,
Published in: